Immunohistochemical expression of TFF1 is a new prognostic marker in retinoblastoma

Rosario Aschero, Daiana Ganiewich, Gabriela Lamas, Camilo A Restrepo-Perdomo, Daniela Ottaviani, Santiago Zugbi, Sandra Camarero, Ezequiel Néspoli, Maria Cuadrado Vilanova, Sara Perez-Jaume, Guillem Pascual-Pasto, Claudia Sampor, Nathalia Grigorovski, Beatriz Salas, Mariona Suñol, Angel M. Carcaboso, Jaume Mora, María T G de Dávila, François Doz, François Radvanyi, David H Abramson, Andrea S Llera, Paula S Schaiquevich, Fabiana Lubieniecki, Guillermo L Chantada
doi: https://doi.org/10.1101/2023.07.24.23293064

Article Information

doi 
https://doi.org/10.1101/2023.07.24.23293064
History 
  • July 27, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Rosario Aschero, PhD1,2,3,4,
  2. Daiana Ganiewich, BEng5,
  3. Gabriela Lamas, MD1,
  4. Camilo A Restrepo-Perdomo, MD6,
  5. Daniela Ottaviani, Ph7,
  6. Santiago Zugbi, Bs2,8,
  7. Sandra Camarero, AS1,
  8. Ezequiel Néspoli, AS1,
  9. Maria Cuadrado Vilanova, PhD3,4,
  10. Sara Perez-Jaume, PhD3,4,
  11. Guillem Pascual-Pasto, PhD3,4,
  12. Claudia Sampor, MD9,
  13. Nathalia Grigorovski, MD10,
  14. Beatriz Salas, MD11,
  15. Mariona Suñol, MD6,
  16. Angel M. Carcaboso, PhD3,4,
  17. Jaume Mora, MD, PhD3,4,
  18. María T G de Dávila, MD, PhD1,
  19. François Doz, MD7,
  20. François Radvanyi, PhD7,
  21. David H Abramson, MD12,
  22. Andrea S Llera, PhD2,5,13,
  23. Paula S Schaiquevich, PhD2,8,
  24. Fabiana Lubieniecki, MD1 and
  25. Guillermo L Chantada, MD, PhD2,3,4,14,*
  1. 1Pathology Service, Hospital de Pediatría JP Garrahan, Buenos Aires 1245, Argentina
  2. 2National Scientific and Technical Research Council, CONICET, Buenos Aires 1425, Argentina
  3. 3SJD Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu, Barcelona, 08950, Spain
  4. 4Institut de Recerca Sant Joan de Deu, Barcelona, 08950, Spain
  5. 5Instituto de Investigaciones en Medicina Traslacional - Universidad Austral, Buenos Aires, Argentina
  6. 6Pathology Service, Hospital Sant Joan de Deu, Barcelona, 08950, Spain
  7. 7SIREDO Center, Institut Curie and University Paris Cité, Paris, France
  8. 8Unidad de tratamientos innovadores, Hospital de Pediatría JP Garrahan, Buenos Aires 1245, Argentina
  9. 9Hematology-Oncology Service, Hospital de Pediatría JP Garrahan, Buenos Aires 1245, Argentina
  10. 10Department of Pediatric Oncology, Clinical Division, National Institute of Cancer, Rio de Janeiro, Brazil
  11. 11Hospital del Niño Manuel A. Villarroel, Cochabamba 2500, Bolivia
  12. 12Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, NY 10065, US
  13. 13Laboratory of Molecular and Cellular Therapy, Instituto Leloir-Instituto de Investigaciones Bioquímicas de Buenos Aires (IIBBA), Buenos Aires 1405, Argentina
  14. 14Hematology Oncology Service, Hospital Pereyra Rossell, Montevideo, Uruguay
  1. ↵*Address for correspondence: Dr Guillermo L Chantada, Hospital Sant Joan de Déu. Pediatric Cancer Center Barcelona, Santa Rosa 39-57, 08950 Esplugues de Llobregat, Barcelona, Spain. Email: guillermoluis.chantada{at}sjd.es
Back to top
Posted July 27, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Immunohistochemical expression of TFF1 is a new prognostic marker in retinoblastoma
Rosario Aschero, Daiana Ganiewich, Gabriela Lamas, Camilo A Restrepo-Perdomo, Daniela Ottaviani, Santiago Zugbi, Sandra Camarero, Ezequiel Néspoli, Maria Cuadrado Vilanova, Sara Perez-Jaume, Guillem Pascual-Pasto, Claudia Sampor, Nathalia Grigorovski, Beatriz Salas, Mariona Suñol, Angel M. Carcaboso, Jaume Mora, María T G de Dávila, François Doz, François Radvanyi, David H Abramson, Andrea S Llera, Paula S Schaiquevich, Fabiana Lubieniecki, Guillermo L Chantada
medRxiv 2023.07.24.23293064; doi: https://doi.org/10.1101/2023.07.24.23293064
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area